Our co-founder Christina Jackson is one of a panel of industry experts discussing the barriers pharmaceutical companies can benefit from addressing. Her takeaway advice? Pharma needs to take more risks in being transparent with patients. ‘From my experience, pharma is...

Our co-founder Lina Eliasson co-authored a recently published paper highlighting the need for emotional and practical support for families caring for a child with Neuronal Ceroid Lipofuscinosis Type 2 Disease (CLN2), a rare degenerative neurometabolic condition that...

The coronavirus crisis has been a shock to us all – and has meant a sudden and dramatic change in the way we live. Many of us are no longer able to follow the routines that keep us healthy, both mentally and physically, such as exercising and socialising. As health...

Sprout founders Lina Eliasson and Christina Jackson, and Sarah Clifford who recently launched our US office, have all worked on a fascinating new paper on the International Society for Medication Adherence (ESPACOMP) Medication Adherence Reporting Guideline (EMERGE)....

We were very proud to present a poster on our nurse-delivered caregiver support program for Hunter syndrome at the 2019 Connect For Care, an international meeting for rare disease nurses. Hunter syndrome is a very rare inherited metabolic disorder, which can cause a...

Our co-founder, Christina Jackson, has co-authored a newly published paper with academics at King’s College London, reporting on testing a brief screener to prompt discussions about adherence in routine consultations. The team worked with 161 people with type 2...